Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Report

China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 17, 2023
  • PAGES：218
  • REPORT CODE：GMM1740203
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GE Healthcare

    • Leica Biosystems Nussloch GmBH

    • Qiagen NV

    • Agilent Technologies

    • Thermo Fisher Scientific Inc

    • Foundation Medicine

    • F Hoffman La Roche

    By Type:

    • PCR

    • Immunohistochemistry

    • Others

    • In-situ Hybridization

    • Sequencing

    By Application:

    • Neurological Disorders

    • Immunological Disorders

    • Others

    • Oncology

    • Cardiovascular Disease

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Overview 2018-2029

    • 1.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Development Overview

    • 1.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Development History

    • 1.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Market Size (2018-2029)

    • 1.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis by Type from Production Side

      • 1.4.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of PCR (2018-2029)

      • 1.4.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Immunohistochemistry (2018-2029)

      • 1.4.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Others (2018-2029)

      • 1.4.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of In-situ Hybridization (2018-2029)

      • 1.4.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

    • 1.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis by Application from Consumption End

      • 1.5.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

      • 1.5.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Immunological Disorders (2018-2029)

      • 1.5.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

    • 1.6 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis by Region

      • 1.6.1 North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Status and Competition Analysis in 2023

      • 2.2.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Development

    Chapter 3 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx)Industry Chain Analysis

    • 3.1 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Chain

    • 3.2 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market

    • 3.3 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market

    Chapter 4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 4.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate, by Type

      • 4.5.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of PCR

      • 4.5.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Immunohistochemistry

      • 4.5.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Others

      • 4.5.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of In-situ Hybridization

      • 4.5.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Sequencing

    Chapter 5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate, by Application

      • 5.5.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Neurological Disorders

      • 5.5.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Immunological Disorders

      • 5.5.3 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Others

      • 5.5.4 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Oncology

      • 5.5.5 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Cardiovascular Disease

    Chapter 6 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Region

    • 6.1 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Production Value, by Region

    • 6.2 China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume and Sales Value, by Region

    Chapter 7 North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 7.1 North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 7.2 North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 8 Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 8.1 Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 8.2 Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 9 South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 9.1 South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 9.2 South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 10 East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 10.1 East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 10.2 East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 11 Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 11.1 Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 11.2 Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 12 Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 12.1 Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 12.2 Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 13 Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Analysis

    • 13.1 Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Type

    • 13.2 Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GE Healthcare

        • 14.1.1 GE Healthcare Company Profile

        • 14.1.2 GE Healthcare Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Leica Biosystems Nussloch GmBH

        • 14.2.1 Leica Biosystems Nussloch GmBH Company Profile

        • 14.2.2 Leica Biosystems Nussloch GmBH Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Qiagen NV

        • 14.3.1 Qiagen NV Company Profile

        • 14.3.2 Qiagen NV Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Agilent Technologies

        • 14.4.1 Agilent Technologies Company Profile

        • 14.4.2 Agilent Technologies Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Thermo Fisher Scientific Inc

        • 14.5.1 Thermo Fisher Scientific Inc Company Profile

        • 14.5.2 Thermo Fisher Scientific Inc Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Foundation Medicine

        • 14.6.1 Foundation Medicine Company Profile

        • 14.6.2 Foundation Medicine Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 F Hoffman La Roche

        • 14.7.1 F Hoffman La Roche Company Profile

        • 14.7.2 F Hoffman La Roche Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Performance

        • 14.7.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Research Conclusions

    • 15.2 Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Market Size (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of PCR (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Immunohistochemistry (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of In-situ Hybridization (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Neurological Disorders (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Immunological Disorders (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume, Sales Value and Growth Rate of Cardiovascular Disease (2018-2029)

    • Figure North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate from 2018-2029

    • Figure Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Share by Type in 2018

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Share by Type in 2023

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of PCR (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Immunohistochemistry (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of In-situ Hybridization (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume and Growth Rate of Sequencing (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Share by Application in 2018

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Share by Application in 2023

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Total Market Size and Growth Rate from Consumption End

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Neurological Disorders (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Immunological Disorders (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Market Size and Growth Rate of Cardiovascular Disease (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Region (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Value by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Value Share by Region (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Value Share by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Region (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Value by Region (2018-2023)

    • Table China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Value Share by Region (2018-2023)

    • Figure China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Value Share by Region (2018-2023)

    • Table North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure North China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure Central China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure South China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure East China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume by Type (2018-2023)

    • Table Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Production Volume Share by Type (2018-2023)

    • Table Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume by Application (2018-2023)

    • Table Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Sales Volume Share by Application (2018-2023)

    • Table GE Healthcare Company Profile

    • Table GE Healthcare Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table Leica Biosystems Nussloch GmBH Company Profile

    • Table Leica Biosystems Nussloch GmBH Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table Qiagen NV Company Profile

    • Table Qiagen NV Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Inc Company Profile

    • Table Thermo Fisher Scientific Inc Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table Foundation Medicine Company Profile

    • Table Foundation Medicine Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)

    • Table F Hoffman La Roche Company Profile

    • Table F Hoffman La Roche Pharmacogenomics Technology-Theranostics-Companion Diagnostics (CDx) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US